Resultados de la búsqueda 191-200 of 4015 for Infertility Treatments
This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...
PLX038 for the Treatment of Metastatic Ovarian, Peritoneal, and Fallopian Tube Cancers. Rochester, Minn. The purpose of this study is to determine the response ...
It is not yet known whether selumetinib works better in treating patients with NF1-associated low-grade glioma compared to standard therapy with carboplatin and ...
This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has come ...
ID predictors of surgical outcomes to identify/improve future treatments -Collect data, images, from patients undergoing surgical treatment of hip disorders ...
The overall goal of this study is to understand if adding inotuzumab ozogamicin to standard of care chemotherapy maintains or improves outcomes in High Risk B- ...
Radiation is typically given in 6-7 weeks for head and neck cancer using X-ray therapy, but this study will administer treatment in approximately 3 weeks. To ...
... treat multiple myeloma. Fertility Outcomes in Lymphoma Patients. Jacksonville, Fla. The objectives of this study are to analyze impact of radiation on fertility ...
This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?